Label: ENEMEEZ PLUS- docusate sodium and benzocaine liquid
-
NDC Code(s):
17433-9877-0,
17433-9877-2,
17433-9877-3,
17433-9877-5, view more17433-9877-6, 17433-9877-7
- Packager: Enemeez LLC DBA Summit Pharmaceuticals
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 23, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- PURPOSE
- Uses
- Warnings
- Ask a doctor before use if you have:
- ASK DOCTOR/PHARMACIST
-
Stop use and ask a doctor if you:
- have rectal bleeding.
- failed to have a bowel movement after use. This may indicate a serious condition.
- encounter resistance. Forcing the tube may result in injury or damage to the rectum. If product is not administered properly and occasional rectal examinations are not performed, serious complications can arise. Occasional rectal exams are imperative for patients with impaired rectal function, especially loss of sensation.
- require a bowel program for longer than 1 week.
- experience rectal irritation or a rash around the anus appears.
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
- OVERDOSAGE
-
Directions
Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children 2 years and over but not more than 12 years should consult a doctor prior to use and not exceed one unit daily (with adult supervision).
Twist off and remove tip; Lubricate tip prior to insertion: Place a few drops of water or product on the shaft prior to insertion. Also apply one of these lubricants to the anus before inserting the enema. With steady pressure, gently insert the tube into the rectum with care to prevent damage to the rectal wall. Squeeze to empty the contents. Continue squeezing the tube until it is removed from the rectum. Remove the disposable tube and discard. A small amount of liquid may remain in the tube after use.
Positioning:
For best results, lay on the left side with knees bent.Alternate Positions:
- Administer while seated on the toilet.
- Kneel with the left arm folded comfortably, then lower head and chest forward until side of face is resting on the surface.
- Other Information
- Inactive Ingredients
- QUESTIONS
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
ENEMEEZ PLUS
docusate sodium and benzocaine liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:17433-9877 Route of Administration RECTAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM 283 mg in 5 mL BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE 20 mg in 5 mL Inactive Ingredients Ingredient Name Strength POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ) GLYCERIN (UNII: PDC6A3C0OX) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:17433-9877-3 30 in 1 CONTAINER 06/15/2012 1 NDC:17433-9877-0 5 mL in 1 TUBE; Type 0: Not a Combination Product 2 NDC:17433-9877-6 35 in 1 CONTAINER 10/08/2021 2 NDC:17433-9877-0 5 mL in 1 TUBE; Type 0: Not a Combination Product 3 NDC:17433-9877-5 5 in 1 CONTAINER 01/14/2022 3 NDC:17433-9877-0 5 mL in 1 TUBE; Type 0: Not a Combination Product 4 NDC:17433-9877-7 6 in 1 CONTAINER 09/14/2023 02/23/2024 4 NDC:17433-9877-0 5 mL in 1 TUBE; Type 0: Not a Combination Product 5 NDC:17433-9877-2 2 in 1 CONTAINER 01/26/2024 5 NDC:17433-9877-0 5 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M007 06/15/2012 Labeler - Enemeez LLC DBA Summit Pharmaceuticals (010717819) Registrant - Enemeez LLC DBA Summit Pharmaceuticals (010717819) Establishment Name Address ID/FEI Business Operations Enemeez LLC DBA Summit Pharmaceuticals 010717819 manufacture(17433-9877)